Effect of Taroneh on treatment of male infertillity
Phase 3
- Conditions
- male infertility.Male infertility
- Registration Number
- IRCT2014111519965N1
- Lead Sponsor
- Vice chancellor for research, Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Male
- Target Recruitment
- 80
Inclusion Criteria
Inclusion Criteria: Idiopathic oligospermia; Idiopathic Asthenospermia; Idiopathic Teratospermia; Idiopathic Oligoasthenospermia; Idiopathic Oligoteratospermia; Idiopathic Oligoteratoasthenospermia; 18-35 Age; Patient’s wife age 18-35; Absence of azoospermia; Non-consuming use of other drug for
treatment of infertility during the study
Exclusion criteria: lack of patient cooperation; the incidence of
serious side effects, Age more than 35, Age of patient’s spouse more than 35
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sperm count concentration. Timepoint: Before intervention and then four months after the start of intervention (one month after the end of intervention). Method of measurement: Semen analysis.;Total sperm count. Timepoint: Before intervention and then four months after the start of intervention (one month after the end of intervention). Method of measurement: Semen analysis.;Motility. Timepoint: Before intervention and then four months after the start of intervention (one month after the end of intervention). Method of measurement: Semen analysis.;Morphology. Timepoint: Before intervention and then four months after the start of intervention (one month after the end of intervention). Method of measurement: Semen analysis.
- Secondary Outcome Measures
Name Time Method pper respiratory tract's reaction to Taroneh. Timepoint: When the incidence of adverse drug reactions in patient. Method of measurement: According CTC (Common Toxicity Criteria).;Volume. Timepoint: Before intervention and then four months after the start of intervention (one month after the end of intervention). Method of measurement: Semen analysis.;Viscosity. Timepoint: Before intervention and then four months after the start of intervention (one month after the end of intervention). Method of measurement: Semen analysis.